Revenue Recognition Segment revenue by major payor (Tables)

6 Months Ended

Jun. 30, 2021

Disaggregation of Revenue [Table Text Block]

The following table summarizes the Company's segment revenues by primary payor source:


	Three months ended June 30, 2021						Three months ended June 30, 2020
	U.S. dialysis		Other - Ancillary services		Consolidated		U.S. dialysis		Other - Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage(1)	$	1,562,164	$		$	1,562,164	$	1,547,113	$		$	1,547,113
Medicaid and Managed Medicaid	194,641				194,641		182,324				182,324
Other government(1)	82,317		118,464		200,781		86,954		90,813		177,767
Commercial	830,801		50,817		881,618		850,558		35,557		886,115
Other revenues:
Medicare and Medicare Advantage			80,211		80,211				99,829		99,829
Medicaid and Managed Medicaid			305		305				283		283
Commercial			1,189		1,189				9,050		9,050
Other(2)	6,415		10,503		16,918		7,995		9,103		17,098
Eliminations of intersegment revenues	(21,317)		—		(21,317)		(35,429)		(4,171)		(39,600)
Total	$	2,655,021	$	261,489	$	2,916,510	$	2,639,515	$	240,464	$	2,879,979

(1)During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the “Other government” category to the “Medicare and Medicare Advantage” category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the three months ended June 30, 2020 has also been recast to conform to the current period presentation.

(2)Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.


	Six months ended June 30, 2021						Six months ended June 30, 2020
	U.S. dialysis		Other - Ancillary services		Consolidated		U.S. dialysis		Other - Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage(1)	$	3,042,461	$		$	3,042,461	$	3,078,146	$		$	3,078,146
Medicaid and Managed Medicaid	381,884				381,884		353,791				353,791
Other government(1)	162,501		225,293		387,794		170,052		185,387		355,439
Commercial	1,666,280		102,315		1,768,595		1,676,140		75,024		1,751,164
Other revenues:
Medicare and Medicare Advantage			165,807		165,807				198,307		198,307
Medicaid and Managed Medicaid			605		605				649		649
Commercial			7,223		7,223				19,571		19,571
Other(2)	13,091		21,665		34,756		13,438		26,705		40,143
Eliminations of intersegment revenues	(48,320)		(4,294)		(52,614)		(67,670)		(8,324)		(75,994)
Total	$	5,217,897	$	518,614	$	5,736,511	$	5,223,897	$	497,319	$	5,721,216

(1)During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the “Other government” category to the “Medicare and Medicare Advantage” category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the six months ended June 30, 2020 has also been recast to conform to the current period presentation.

(2)Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.